Overview

Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results

Status:
Completed
Trial end date:
2015-12-17
Target enrollment:
Participant gender:
Summary
This trial is conducted in Africa, Asia, Europe, and North and South America. The aim of this trial is to determine the long term effect of liraglutide on cardiovascular events in subjects with type 2 diabetes.
Phase:
Phase 3
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Liraglutide